CN Stock MarketDetailed Quotes

600380 Joincare Pharmaceutical Group Industry

Watchlist
  • 11.44
  • +0.04+0.35%
Noon Break Dec 5 11:29 CST
21.44BMarket Cap14.57P/E (TTM)

About Joincare Pharmaceutical Group Industry Company

The company was founded in 1992 and has now become an innovative research-based comprehensive pharmaceutical group under the two-wheel drive of an innovative and high-barrier technology platform. The Group has always insisted on scientific and technological innovation as its strategic base. The company is mainly engaged in R&D, production and sales of pharmaceutical products and health products. The company's main products are chemical preparations, biological products, chemical raw materials and intermediates, traditional Chinese medicine preparations, diagnostic reagents and equipment, health food, etc. The company received the Honorary Humane Service Award, the 2nd China's Top 20 Most Competitive Pharmaceutical Listed Companies, the 2nd China's Top 20 Most Competitive Pharmaceutical Listed Companies, and the 2010 Top 100 Taxpayer Companies.

Company Profile

Short Name-A健康元
Symbol-A600380
Company NameJoincare Pharmaceutical Group Industry Co., LTD
Listing DateJun 8, 2001
Issue Price24.80
Shares Offered70.00M share(s)
FoundedDec 18, 1992
Listed ExchangeSH Stock Exchange
Legal Representativebaoguo zhu
General Managernanqi lin
Secretaryyifan zhu
Accounting FirmGrant Thornton Certified Public Accountants (Special General Partnership)
Securities Representativehongtaoluoxiao li
Legal CounselBeijing Deheng (Shenzhen) Law Firm
Employees1070
Phone0755-86252656
Office AddressHealth Yuan Pharmaceutical Group Building, No. 17 Langshan Road, North District, High-tech Zone, Nanshan District, Shenzhen
Zip Code518057
Registered AddressHealth Yuan Pharmaceutical Group Building, No. 17 Langshan Road, North District, High-tech Zone, Nanshan District, Shenzhen
Fax0755-86252165
Emailjoincare@joincare.com
Business License440301501126176
BusinessGeneral business projects: contract production of pharmaceuticals; technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion. (Except for projects that require approval according to law, business activities are carried out independently in accordance with the law with a business license) Licensed business projects: R&D of proprietary Chinese medicines, chemical raw materials, chemical agents, antibiotic raw materials, antibiotic formulations (research and development of Chinese herbal medicines and proprietary Chinese medicine secret products that do not include state protected resources), wholesale, import and export and related supporting services (not involving state-owned trade management products, involving quotas, license management, and other products managed by special regulations; processing applications in accordance with relevant national regulations); research and development of food, health food, and cosmetics; refrigerated sales of pre-packaged food (excluding refrigerated food) food), special Food sales (health food sales, special medical formula sales), R&D and sales of Class I and Class II medical devices. Class I medical device production; Class II medical device production; Class III medical device production; Class III medical device management. (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments. Specific business projects are subject to documents or licenses approved by the relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • baoguo zhu
  • Chairman, Directors, Chairman of the Commission on Sustainable Development, Chairman of the Strategy and Risk Management Committee
  • 3.34M
  • guangxia liu
  • Vice Chairman, Directors
  • 4.37M
  • zhiwei xing
  • Directors, VP, Member of the Commission on Sustainable Development
  • 1.12M
  • nanqi lin
  • Directors, President, Member of the Strategy and Risk Management Committee
  • 2.26M
  • qingfeng qiu
  • Directors, VP, Head of Finance, Nomination Committee Members
  • 2.26M
  • xiaoxing yin
  • Independent Directors, Audit Committee Member, Member of the Strategy and Risk Management Committee, Chairman of the Nomination Committee
  • 35.00K
  • juan peng
  • Independent Directors, Member of the Commission on Sustainable Development, Audit Committee Member, Member of the Remuneration and Assessment Committee
  • 120.00K
  • yezhi tan
  • Independent Directors, Member of the Strategy and Risk Management Committee, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
  • 120.00K
  • jing huo
  • Independent Directors, Chairman of the Remuneration and Assessment Committee, Nomination Committee Members, Member of the Strategy and Risk Management Committee
  • 120.00K
  • yifan zhu
  • Board Secretary
  • --
  • hongtao li
  • Securities Affairs Representative
  • --
  • xiao luo
  • Securities Affairs Representative
  • --
  • xiaoyun yu
  • Chairman of the Supervisory Board, Employee Supervisors
  • 703.60K
  • jinhua peng
  • Auditors
  • 48.00K
  • nan li
  • Auditors
  • --
  • tingke tang
  • VP
  • --
  • leiming zhang
  • VP
  • 2.02M
  • yanmei du
  • VP
  • --
  • fengguang zhao
  • VP
  • 2.06M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data